IL-4Ra (CD124), Fc-Fusion (lgG1), Avi-Tag Recombinant

IL-4Ra (CD124), Fc-Fusion (lgG1), Avi-Tag Recombinant
SKU
BPS102467-2
Packaging Unit
100 µg
Manufacturer
BPS Bioscience

Availability: loading...
Price is loading...
Products from BPS Bioscience require a minimum order value above 400€

Encompassing Amino Acids: 26-232

Application: Useful for binding assays.

Assay Conditions: A white 96-well plate was precoated with IL-4, His-Avi-Tag Recombinant (#102538) (100 ng/well). Blocking Buffer 2 (#79728) and PBST were used for blocking and washing steps, respectively. For protein titration a serial dilution of IL-4Ra (CD124), Fc-Fusion (lgG1), Avi-Tag Recombinant (#102467) at the highest concentration of 10 ng/µl (250 ng/reaction) was prepared in 1x PP-02 Assay Buffer. Diluted IL-4Ra was then added to the wells and incubated at Room Temperature (RT) for 1 hour. The plate was then washed again and incubated with anti-Fc-HRP conjugate diluted 1:1000 in Blocking Buffer 2 for 1 hour at RT. After the final wash, ELISA ECL substrate mix (#79670) was added to each well and chemiluminescence was read.

Background: Interleukin-4 is produced mainly by a subpopulation of activated T cells (Th2) that are the biologically most active helper cells for B cells and secrete IL-5 and IL-6. The biological activities of IL-4 are mediated by a specific receptor. The extracellular domain of the IL-4 receptor is related to the receptors for EPO (erythropoietin), IL-6, and the beta chain of the IL-2 receptor (CD122). There are two types of receptors for IL-4. Type 1 receptor is a heterodimer consisting of IL-4Ralpha (IL4-Rα) and  IL-4Rgamma ( IL-4Rγc), mostly present on hematopoietic cells. The type 2 receptor is a heterodimer consisting of IL-4Ralpha and IL-13Ralpha1 (Il-13Rα1). IL-4 enhances expression of MHC (major histocompatibility class) 2 antigens on B cells. It can promote their capacity to respond to other B cell stimuli and to present antigens for T cells. Pretreatment of macrophages with IL-4 prevents the production of IL-1, TNFα (tumor necrosis factor alpha) and prostaglandins in response to activation by bacterial endotoxins or IFN-γ (interferon gamma). IL-4 plays crucial roles in inflammation, fibrosis, allergic reactions, and cancer. The therapeutic exploitation of IL-4 signaling pathways can advance the treatment of auto-immune disorders.

Description: Recombinant IL-4Ra (interleukin-4 receptor subunit alpha), transcript variant 1, also known as CD124, encompassing amino acids 26-232 of the extracellular domain. This construct contains the Fc domain of human IgG1 fused to the C-terminus, followed by a C-terminal Avi-Tag™. The recombinant protein was affinity purified.

Format: Aqueous buffer solution

Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

Genbank: NM_000418.4

Host Cell Line: HEK293

Purity: ≥85%

Storage Stability: At least 6 months at -80°C.

Tags: Fc-Avi

Target: IL-4Ra

Uniprot: P24394

Unit Definition: Protein

Warnings: Avoid freeze/thaw cycles.

Biosafety Level: Not applicable (BSL-1)
More Information
SKU BPS102467-2
Manufacturer BPS Bioscience
Manufacturer SKU 102467-2
Package Unit 100 µg
Quantity Unit STK
Host Human
Product information (PDF) Download
MSDS (PDF)
×